Purple Biotech (PPBT) Return on Sales (2014 - 2019)

Purple Biotech's (PPBT) quarterly Return on Sales came in at 0.24% in Q4 2019, up 2639.49% on a QoQ basis from 0.01% in Q4 2014.

Purple Biotech (PPBT) Return on Sales (2014 - 2019) Analysis & Trends

Purple Biotech (PPBT) has 2 years of Return on Sales data on file, last reported at 0.24% in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.00%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.00%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	0.00%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Purple Biotech	1.33 Bn	1.33 Bn	-	-

Download Data

Date	Value
Dec 31, 2019	0.24%
Dec 31, 2014	-0.01%